In this presentation, Dr. Jorge Mera, ECHO Medical Director and Director of Infectious Diseases for Cherokee Nation Health Services, discusses the latest COVID-19 clinical updates, mask guidance, variants, treatments and… […]
Audience: Clinical
Vital Statistics Rapid Release (CDC)
This data visualization presents provisional counts for drug overdose deaths based on a current flow of mortality data in the National Vital Statistics System. Counts for the most recent final… […]
Omicron Variant (CDC)
One-stop-shop of all CDC information and statistics available on the COVID-19 Omicron variant in the United States. […]
COVID-19 Vaccine Comparison Chart (The Medical Letter)
Comparison chart of vital information on the available COVID-19 vaccines. […]
Read More… from COVID-19 Vaccine Comparison Chart (The Medical Letter)
COVID-19 Drug Interaction Checker (University of Liverpool)
Easy-to-use database of COVID-19 drug interactions. […]
Read More… from COVID-19 Drug Interaction Checker (University of Liverpool)
Innovative Strategies in Harm Reduction: Text-Based Care | March 1, 2022
In this presentation, Dr. Samantha Gustafson, PharmD, describes the impact of the COVID-19 pandemic on harm reduction strategies, and identifies promising practices in text-based, contactless care. […]
Read More… from Innovative Strategies in Harm Reduction: Text-Based Care | March 1, 2022
Behavioral Health ECHO | February 24, 2022
In this session, Behavioral Health ECHO faculty members and participants join in a discussion of the previous training, Cultural Based Strategies, held on January 27, 2022. […]
Syphilis in the ED: Why it Matters and What to Know | March 3, 2022
We welcome you to join Indian Country ECHO for a special session focused on responding to the rise of syphilis rates in Indigenous communities. This session will cover syphilis’ reemergence… […]
Read More… from Syphilis in the ED: Why it Matters and What to Know | March 3, 2022
Residual Risk for HCC in Patients After HCV SVR | February 23, 2022
In this presentation, Dr. Raymond Chung, 2021 AASLD President and Director of Hepatology and the Liver Center at Massachusetts General Hospital, discusses the residual risk for hepatocellular carcinoma in patients after… […]
Read More… from Residual Risk for HCC in Patients After HCV SVR | February 23, 2022
Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Highly Effective Biomedical Option | February 23, 2022
In this series of presentations focused on Pre-Exposure Prophylaxis (PrEP) for HIV Prevention, Dawn K. Smith, MD, MS, MPH, and Demetre Daskalakis, MD, MPH cover the evidence on effectiveness, monitoring, and best… […]
